Tag: MorphoSys
Novartis offers 2.7 billion euros for Munich biotech company Morphosys – Economy
The Swiss pharmaceutical company Novartis is reaching out to the biotech company Morphosys. The Swiss are spending 2.7 billion euros on this. Novartis is particularly interested in the promising pelabresib…
Market report: Tug of war between DAX bulls and bears
market report As of: February 6, 2024 7:29 a.m The DAX is likely to start trading with slight price gains and thus move somewhat closer to the 17,000 point mark.…
MorphoSys shares slide by double digits: MorphoSys plans to apply for approval for hopeful pelabresib in mid-2024 November 21, 2023
The drug researcher MorphoSys has achieved a breakthrough in clinical tests with its hopeful pelabresib. The Bavarians met their most important goal in a study relevant to approval and now…
Take a hit: MorphoSys shares and Roche shares plummet: Roche and MorphoSys miss targets in important Alzheimer’s study | news
shares in this article Alzheimer’s is still considered a risky bet in research. The pharmaceutical company Roche also received this on Monday. The Alzheimer’s program with the candidate gantenerumab has…
Biotech stock plummets: Alzheimer’s disease hits MorphoSys hard
Status: 11/14/2022 3:46 p.m The German biotech company MorphoSys and its partner, the Swiss pharmaceutical giant Roche, have suffered a major setback in research. A potential drug to treat Alzheimer’s…